首页> 美国卫生研究院文献>other >Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice
【2h】

Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice

机译:番茄红素通过依赖于类胡萝卜素裂解酶的不同机制减弱小鼠肝肿瘤的发生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Obesity is associated with increased liver cancer risks and mortality. We recently showed that apo-10’-lycopenoic acid, a lycopene metabolite generated by beta-carotene-9’,10’-oxygenase (BCO2), inhibited carcinogen-initiated, high-fat diet (HFD)-promoted liver inflammation and hepatic tumorigenesis development. The present investigation examined the outstanding question of whether the lycopene could suppress HFD-promoted hepatocellular carcinoma (HCC) progression, and if BCO2 is important in BCO2-knockout (BCO2-KO) and wild-type male mice. Results showed that lycopene supplementation (100 mg/kg diet) for 24 weeks resulted in comparable accumulation of hepatic lycopene (19.4 vs 18.2 nmol/g) and had similar effects on suppressing HFD-promoted HCC incidence (19% vs 20%) and multiplicity (58% vs 62%) in wild-type and BCO2-KO mice, respectively. Intriguingly, lycopene chemopreventive effects in wild-type mice were associated with reduced hepatic pro-inflammatory signaling (phosphorylation of nuclear factor-κB p65 and signal transducer and activator of transcription 3; interleukin-6 protein) and inflammatory foci. In contrast, the protective effects of lycopene in BCO2-KO but not in wild-type mice were associated with reduced hepatic endoplasmic reticulum stress-mediated unfolded protein response (ERUPR), through decreasing ERUPR-mediated protein kinase RNA-activated like kinase– eukaryotic initiation factor 2α activation, and inositol requiring 1α–X-box binding protein 1 signaling. Lycopene supplementation in BCO2-KO mice suppressed oncogenic signals including Met mRNA, β-catenin protein, and mammalian target of rapamycin (mTOR) complex 1 activation, which was associated with increased hepatic microRNA (miR)-199a/b and miR-214 levels. These results provided novel experimental evidence that dietary lycopene can prevent HFD-promoted HCC incidence and multiplicity in mice, and may elicit different mechanisms depending on BCO2 expression.
机译:肥胖与增加的肝癌风险和死亡率有关。我们最近发现,由β-胡萝卜素9',10'-加氧酶(BCO2)生成的番茄红素代谢产物apo-10'-番茄红素抑制致癌物引发的高脂饮食(HFD)促进肝脏炎症和肝炎肿瘤发生发展。本研究调查了番茄红素是否可以抑制HFD促进的肝细胞癌(HCC)进展,以及BCO2是否对BCO2-敲除(BCO2-KO)和野生型雄性小鼠重要。结果显示,补充番茄红素(100 mg / kg饮食)持续24周可导致相当数量的肝番茄红素积聚(19.4 vs 18.2 nmol / g),并且在抑制HFD促进的HCC发生率(19%vs 20%)和多样性方面具有相似的作用。 (58%和62%)分别在野生型和BCO2-KO小鼠中表现出来。有趣的是,番茄红素对动物的化学预防作用与减少的肝脏促炎信号(核因子-κBp65的磷酸化以及信号转导和转录激活因子3;白介素-6蛋白)和炎性灶有关。相比之下,番茄红素对BCO2-KO的保护作用而非对野生型小鼠的保护作用与通过降低ER 减少的肝内质网应激介导的未折叠蛋白反应(ER UPR )有关。 UPR 介导的蛋白激酶像激酶–真核生物起始因子2α一样被激活,而肌醇则需要1α–X-box结合蛋白1信号。在BCO2-KO小鼠中补充番茄红素抑制了致癌信号,包括Met mRNA,β-catenin蛋白和雷帕霉素(mTOR)复合物1激活的哺乳动物靶标,这与肝脏microRNA(miR)-199a / b和miR-214水平升高相关。这些结果提供了新颖的实验证据,表明饮食中的番茄红素可以预防HFD促进的HCC发生和小鼠多发,并可能根据BCO2的表达引发不同的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号